Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Scarffe

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Hematological Oncology|January 1, 1989
Cyclosporin associated demyelination following allogeneic bone marrow transplantationM J Lind, L McWilliam, J Jip, et al.
British Journal of Cancer|July 1, 1983
Gynaecomastia complicating the treatment of myelomaD M Large, J M Jones, S M Shalet, et al.
Haematology and Blood Transfusion|January 1, 1987
The use of cultured bone marrow cells for autologous transplantation in patients with acute myeloblastic leukemiaN G Testa, L Coutinho, J Chang, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1984
Observations on the toxicity of the combination of gentamicin and mezlocillin in the treatment of patients with acute leukaemiaE M Rankin, D M Jones, F G Lawston, et al.
Leukemia & Lymphoma|July 1, 1994
Distinctive features of immunoglobulin heavy chain variable region gene rearrangement in multiple myelomaB W Baker, M Deane, M H Gilleece, et al.
The Journal of Hospital Infection|November 1, 1996
Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unitP R Chadwick, B A Oppenheim, A Fox, et al.
Journal of the Royal College of Physicians of London|January 16, 1998
Central venous catheter placement: extending the role of the nurseC L Fitzsimmons, M H Gilleece, M R Ranson, et al.
British Journal of Cancer|January 1, 1989
Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity studyW P Steward, J H Scarffe, R Austin, et al.
Anti-Cancer Drugs|August 1, 1992
A phase II study of sulofenur (LY186641) in gastric cancerA Kamthan, J H Scarffe, J Walling, et al.
British Journal of Cancer|January 1, 1983
Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosisJ A Child, S M Crawford, D R Norfolk, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Hematological Oncology|January 1, 1989
Cyclosporin associated demyelination following allogeneic bone marrow transplantationM J Lind, L McWilliam, J Jip, et al.
British Journal of Cancer|July 1, 1983
Gynaecomastia complicating the treatment of myelomaD M Large, J M Jones, S M Shalet, et al.
Haematology and Blood Transfusion|January 1, 1987
The use of cultured bone marrow cells for autologous transplantation in patients with acute myeloblastic leukemiaN G Testa, L Coutinho, J Chang, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1984
Observations on the toxicity of the combination of gentamicin and mezlocillin in the treatment of patients with acute leukaemiaE M Rankin, D M Jones, F G Lawston, et al.
Leukemia & Lymphoma|July 1, 1994
Distinctive features of immunoglobulin heavy chain variable region gene rearrangement in multiple myelomaB W Baker, M Deane, M H Gilleece, et al.
The Journal of Hospital Infection|November 1, 1996
Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unitP R Chadwick, B A Oppenheim, A Fox, et al.
Journal of the Royal College of Physicians of London|January 16, 1998
Central venous catheter placement: extending the role of the nurseC L Fitzsimmons, M H Gilleece, M R Ranson, et al.
British Journal of Cancer|January 1, 1989
Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity studyW P Steward, J H Scarffe, R Austin, et al.
Anti-Cancer Drugs|August 1, 1992
A phase II study of sulofenur (LY186641) in gastric cancerA Kamthan, J H Scarffe, J Walling, et al.
British Journal of Cancer|January 1, 1983
Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosisJ A Child, S M Crawford, D R Norfolk, et al.
Pageof 13